Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for IMPEL PHARMACEUTICALS INC
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-19
Purchase
2021-11-22
5:05 pm
IMPEL NEUROPHARMA INCIMPLNELSON TIMOTHY S
Director
10,000$10.76$107,55410,000
(Direct)
View
2021-08-18
Purchase
2021-08-19
5:23 pm
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB CEO and President
20,000$13.99$279,79020,000
(Direct)
View
2021-04-27
Purchase
2021-04-29
9:10 pm
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
575,000$15$8,625,000349,674
(Indirect)
View
2021-04-27
Purchase
2021-04-29
8:51 pm
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
575,000$15$8,625,000575,000
(Indirect)
View
2021-04-27
Purchase
2021-04-29
7:45 pm
IMPEL NEUROPHARMA INCIMPLNorwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
825,000$15$12,375,0003,077,198
(Direct)
View
2021-04-27
Purchase
2021-04-29
6:44 pm
IMPEL NEUROPHARMA INCIMPLvenBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
450,000$15$6,750,0002,759,791
(Direct)
View
2021-04-27
Purchase
2021-04-29
5:07 pm
IMPEL NEUROPHARMA INCIMPLKKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
1,100,000$15$16,500,0003,921,350
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-12-31
Tax Withholding
2023-01-04
6:46 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLLeaman John Harold
Chief Fin. & Business Officer
3,627$3.756,944
(Direct)
View
2022-12-31
Exercise
2023-01-04
6:46 pm
N/A
N/A
IMPEL PHARMACEUTICALS INCIMPLLeaman John Harold
Chief Fin. & Business Officer
10,571$06,944
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:06 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLWilfong Diane E.
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:05 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLSHAH MAHENDRA
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:03 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLNELSON TIMOTHY S
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:02 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLPARKER H STEWART
Director
12,789$012,789
(Direct)
View
2022-06-16
Option Award
2022-06-17
5:00 pm
N/A
2032-06-15
IMPEL PHARMACEUTICALS INCIMPLAllison David D.
Director
12,789$012,789
(Direct)
View
2022-03-29
Exercise
2022-03-30
9:54 pm
N/A
2027-02-13
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
24,606$097,990
(Direct)
View
2022-03-29
Exercise
2022-03-30
9:54 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
24,606$1.9797,990
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:06 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
30,000$030,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:05 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLPaolillo Leonard
Chief Commercial Officer
40,000$040,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:04 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLLeaman John Harold
Chief Fin. & Business Officer
100,000$0100,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:03 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
35,000$035,000
(Direct)
View
2022-01-26
Option Award
2022-01-28
5:01 pm
N/A
2032-01-25
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB CEO and President
175,000$0175,000
(Direct)
View
2021-12-22
Exercise
2021-12-23
4:50 pm
N/A
2021-12-22
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
20,000$0128,221
(Direct)
View
2021-12-22
Exercise
2021-12-23
4:50 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
20,000$1.64128,221
(Direct)
View
2021-10-19
Option Award
2021-10-21
5:31 pm
N/A
2031-10-19
IMPEL NEUROPHARMA INCIMPLLeaman John Harold
Chief Fin. & Business Officer
10,571$010,571
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
53,954$2.95103,512
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
2027-10-17
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
73,384$0103,512
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
14,780$1.97103,512
(Direct)
View
2021-09-21
Exercise
2021-09-22
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
4,650$2.46103,512
(Direct)
View
2021-07-20
Option Award
2021-07-26
6:04 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLSHREWSBURY STEPHEN B
Chief Medical Officer
50,000$050,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
6:02 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLPaolillo Leonard
Chief Commercial Officer
30,000$030,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
6:00 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLLeaman John Harold
Chief Financial Officer
50,000$050,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
5:58 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
50,000$050,000
(Direct)
View
2021-07-20
Option Award
2021-07-26
5:58 pm
N/A
2031-07-19
IMPEL NEUROPHARMA INCIMPLADAMS ADRIAN
COB CEO and President
50,000$050,000
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:12 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INCIMPLWilfong Diane E.
Director
11,500$011,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:10 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INCIMPLSHAH MAHENDRA
Director
11,500$011,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:09 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
11,500$011,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:06 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INCIMPLNELSON TIMOTHY S
Director
11,500$011,500
(Direct)
View
2021-07-11
Option Award
2021-07-13
5:05 pm
N/A
2031-07-10
IMPEL NEUROPHARMA INCIMPLAllison David D.
Director
11,500$011,500
(Direct)
View
2021-04-22(A)
Ownership
2021-06-22
5:41 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
0$016,148
(Direct)
View
2021-04-27(A)
Conversion
2021-06-07
4:57 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
73,910$0108,496
(Direct)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
39,725,922$0349,674
(Indirect)
View
2021-04-27
Conversion
2021-04-29
9:10 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
101,456$13.5349,674
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
39,725,924$0575,000
(Indirect)
View
2021-04-27
Conversion
2021-04-29
8:51 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPL5AM Ventures V L.P.
5AM Partners V LLC
PARMAR KUSH
ROCKLAGE SCOTT M
Schwab Andrew J.
5AM Opportunities I L.P.
5AM Opportunities I (GP) LLC
10% Owner
101,457$13.5575,000
(Indirect)
View
2021-04-27
Conversion
2021-04-29
7:45 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INCIMPLNorwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
38,735,370$03,077,198
(Direct)
View
2021-04-27
Conversion
2021-04-29
7:45 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLNorwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
98,927$13.53,077,198
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:44 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLvenBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
39,827,381$02,759,791
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
349,059$0284,584
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
47,263$8.66284,584
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
271$13.5284,584
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
60,992$0284,584
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
13,756$8.19284,584
(Direct)
View
2021-04-27
Other
2021-04-29
6:33 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLPARKER H STEWART
Director
2,124$0284,584
(Direct)
View
2021-04-27
Conversion
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
74,180$0178,153
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
8,523$0178,153
(Direct)
View
2021-04-27
Exercise
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
8,523$8.19178,153
(Direct)
View
2021-04-27
Other
2021-04-29
6:31 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLHoekman John
Chief Scientific Officer
275$0178,153
(Direct)
View
2021-04-27
Conversion
2021-04-29
5:07 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLKKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
44,891,374$03,921,350
(Indirect)
View
2021-04-27
Other
2021-04-29
5:07 pm
N/A
N/A
IMPEL NEUROPHARMA INCIMPLKKR Iris Investors LLC
KKR Healthcare Strategic Growth Fund L.P.
KKR Associates HCSG L.P.
KKR HCSG GP LLC
KKR Group Partnership L.P.
KKR Group Holdings Corp.
KKR & Co. Inc.
KKR Management LLP
KRAVIS HENRY R
ROBERTS GEORGE R
10% Owner
118,712$13.53,921,350
(Indirect)
View
2021-04-22
Other
2021-04-26
7:11 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INCIMPLvenBio Global Strategic Fund II L.P.
venBio Global Strategic GP II L.P.
venBio Global Strategic GP II Ltd.
GOODMAN COREY S
Adelman Robert J
10% Owner
1,359,799$01,359,799
(Direct)
View
2021-04-22
Other
2021-04-26
7:02 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INCIMPLNorwest Venture Partners XIV LP
Crowe Jeffrey
HAQUE PROMOD
Kossow Jon Erik
10% Owner
1,325,893$01,325,893
(Direct)
View
2021-04-22
Other
2021-04-26
6:24 pm
N/A
2021-12-31
IMPEL NEUROPHARMA INCIMPLVivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
1,359,799$01,359,799
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next